Approval · Notice of Compliance 9534 · 2008
TOMUDEX: Notice of Compliance 9534
Issued May 1, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9534
- Date
- May 1, 2008
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMUDEX | 02229566 | Marketed |
Medicinal ingredients
- RALTITREXED 2 MG per VIAL